141 related articles for article (PubMed ID: 24911080)
1. Beneficial role of tamoxifen in experimentally induced cardiac hypertrophy.
Patel BM; Desai VJ
Pharmacol Rep; 2014 Apr; 66(2):264-72. PubMed ID: 24911080
[TBL] [Abstract][Full Text] [Related]
2. Beneficial role of tamoxifen in isoproterenol-induced myocardial infarction.
Rayabarapu N; Patel BM
Can J Physiol Pharmacol; 2014 Oct; 92(10):849-57. PubMed ID: 25243890
[TBL] [Abstract][Full Text] [Related]
3. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.
Rose M; Balakumar P; Singh M
Pharmacology; 2007; 80(2-3):177-84. PubMed ID: 17570955
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway.
Al-Rasheed NM; Al-Oteibi MM; Al-Manee RZ; Al-Shareef SA; Al-Rasheed NM; Hasan IH; Mohamad RA; Mahmoud AM
Drug Des Devel Ther; 2015; 9():3217-29. PubMed ID: 26150695
[TBL] [Abstract][Full Text] [Related]
5. Differential role of rho-kinase in pathological and physiological cardiac hypertrophy in rats.
Balakumar P; Singh M
Pharmacology; 2006; 78(2):91-7. PubMed ID: 16974135
[TBL] [Abstract][Full Text] [Related]
6. Sodium Butyrate Controls Cardiac Hypertrophy in Experimental Models of Rats.
Patel BM
Cardiovasc Toxicol; 2018 Feb; 18(1):1-8. PubMed ID: 28389765
[TBL] [Abstract][Full Text] [Related]
7. Possible role of poly(ADP-ribose) polymerase in pathological and physiological cardiac hypertrophy.
Balakumar P; Singh M
Methods Find Exp Clin Pharmacol; 2006 Dec; 28(10):683-9. PubMed ID: 17235412
[TBL] [Abstract][Full Text] [Related]
8. Impact of obesity on hypertension-induced cardiac remodeling: role of oxidative stress and its modulation by gemfibrozil treatment in rats.
Singh R; Singh AP; Singh M; Krishan P
Free Radic Biol Med; 2011 Jan; 50(2):363-70. PubMed ID: 21118715
[TBL] [Abstract][Full Text] [Related]
9. Beneficial Effect of Silymarin in Pressure Overload Induced Experimental Cardiac Hypertrophy.
Sharma B; Chaube U; Patel BM
Cardiovasc Toxicol; 2019 Feb; 19(1):23-35. PubMed ID: 29968071
[TBL] [Abstract][Full Text] [Related]
10. Beneficial role of spironolactone, telmisartan and their combination on isoproterenol-induced cardiac hypertrophy.
Goyal BR; Mehta AA
Acta Cardiol; 2012 Apr; 67(2):203-11. PubMed ID: 22641978
[TBL] [Abstract][Full Text] [Related]
11. Ameliorative role of gemfibrozil against partial abdominal aortic constriction-induced cardiac hypertrophy in rats.
Singh AP; Singh R; Krishan P
Cardiol Young; 2015 Apr; 25(4):725-30. PubMed ID: 24905340
[TBL] [Abstract][Full Text] [Related]
12. Modulation of impact of high fat diet in pathological and physiological left ventricular cardiac hypertrophy by fluvastatin.
Singh R; Krishan P
Biomed Pharmacother; 2010 Mar; 64(3):147-53. PubMed ID: 20053524
[TBL] [Abstract][Full Text] [Related]
13. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
[TBL] [Abstract][Full Text] [Related]
14. [Oxidative stress and calcium/calmodulin-dependent protein kinase II contribute to the development of sustained β adrenergic receptor-stimulated cardiac hypertrophy in rats].
Liu YL; Liu B; Qu YY; Chai HJ; Li R; Zhang L
Sheng Li Xue Bao; 2013 Feb; 65(1):1-7. PubMed ID: 23426507
[TBL] [Abstract][Full Text] [Related]
15. Perindopril protects against streptozotocin-induced hyperglycemic myocardial damage/alterations.
Patel BM; Agarwal SS; Bhadada SV
Hum Exp Toxicol; 2012 Nov; 31(11):1132-43. PubMed ID: 22653691
[TBL] [Abstract][Full Text] [Related]
16. Kampeferol protects against oxidative stress and apoptotic damage in experimental model of isoproterenol-induced cardiac toxicity in rats.
Suchal K; Malik S; Gamad N; Malhotra RK; Goyal SN; Bhatia J; Arya DS
Phytomedicine; 2016 Nov; 23(12):1401-1408. PubMed ID: 27765360
[TBL] [Abstract][Full Text] [Related]
17. Dimethyl fumarate interferes with MyD88-dependent toll-like receptor signalling pathway in isoproterenol-induced cardiac hypertrophy model.
Ahmed AA; Ahmed AAE; El Morsy EM; Nofal S
J Pharm Pharmacol; 2018 Nov; 70(11):1521-1530. PubMed ID: 30175489
[TBL] [Abstract][Full Text] [Related]
18. Compound 3K attenuates isoproterenol-induced cardiac hypertrophy by inhibiting pyruvate kinase M2 (PKM2) pathway.
Rihan M; Sharma SS
Life Sci; 2024 Aug; 351():122837. PubMed ID: 38879156
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of inducible nitric oxide synthase (iNOS) by simvastatin attenuates cardiac hypertrophy in rats.
Ahmed AM
Folia Morphol (Warsz); 2017; 76(1):15-27. PubMed ID: 27665951
[TBL] [Abstract][Full Text] [Related]
20. EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats.
Sheng R; Gu ZL; Xie ML; Zhou WX; Guo CY
Acta Pharmacol Sin; 2007 Feb; 28(2):191-201. PubMed ID: 17241521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
